The Academy, which comes as part of our expansion, will allow us to develop a skilled team and to support our company growth and expansion plans.
The RoslinCT Training Academy is located within our new state of the art facility and will focus on upskilling the existing staff as well as providing external training as part of the Advanced Therapies Skills Training Network (ATSTN). Key to our success is our people and as we move through this phase of growth, we are developing a team and infrastructure to create high-value and develop potentially lifesaving treatments.
We are also proud that the RoslinCT with our Training Academy has been selected to be leading the Scottish Group as one of three preferred bidders for National Training Centres, to deliver high impact physical and digital training courses in advanced therapy and vaccine manufacturing as part of the growing Advanced Therapies Skills Training Network programme!
Janet Downie, CEO of RoslinCT said: “With Cell and Gene Therapy Manufacturing being at the cutting edge we have taken the strategy to provide the training internally and develop a highly-skilled RoslinCT team. We are delighted to be part of the ATSTN network and be able to share our knowledge more widely. With the tremendous growth in ATMP and Vaccine Manufacturing, we are proud to support a pipeline of talent to support the industry for Scotland and the UK."
The new Training Academy is supported by Scottish Enterprise, with £100,000 in grant funding provided as a contribution towards fully equipping the new facility. David Leven, Head of High Value Manufacturing at Scottish Enterprise, said: “Despite the Covid-19 pandemic, the cell and gene therapy sector has continued to grow and prosper, with demand for manufacturing capacity continuing to increase.
“It’s fantastic to see RoslinCT expand its manufacturing facilities and create this new training academy, which will benefit all of Scotland’s cell and gene therapy companies and enhance our global reputation for life sciences excellence.”
To register interest follow the link below.